Loading...
Loading...
India's azithromycin imports from UNITED STATES total $36.9K across 44 shipments from 15 foreign suppliers. AMSTERDAM PHARMA(APTEKA RX INC.) leads with $10.9K in import value; the top 5 suppliers together control 76.3% of this origin. Leading Indian buyers include AUROBINDO PHARMA LTD. This corridor reflects India's pharmaceutical import demand for azithromycin — a diversified sourcing base with multiple active suppliers from UNITED STATES.

AMSTERDAM PHARMA(APTEKA RX INC.) is the leading Azithromycin supplier from UNITED STATES to India, with import value of $10.9K across 1 shipments. The top 5 suppliers — AMSTERDAM PHARMA(APTEKA RX INC.), ADIRA MEDICA LLC., BIONPHARMA INC.,, CELTIS HEALTHCARE LLC, AGRACE PHARMA — collectively account for 76.3% of total import value from this origin.
Ranked by import value (USD) · Indian Customs (DGFT) data
| # | Supplier | Value (USD) | Shipments | Share |
|---|---|---|---|---|
| 1 | AMSTERDAM PHARMA(APTEKA RX INC.) | $10.9K | 1 | 29.6% |
| 2 | ADIRA MEDICA LLC. | $5.3K | 1 | 14.2% |
| 3 | BIONPHARMA INC., | $4.8K | 2 | 12.9% |
| 4 | CELTIS HEALTHCARE LLC | $3.9K | 1 | 10.6% |
| 5 | AGRACE PHARMA | $3.3K | 7 | 8.9% |
| 6 | ESPEE BIOPHARMA FINECHEM LLC | $2.4K | 1 | 6.4% |
| 7 | ZYDUS HEALTHCARE (USA) LLC | $2.1K | 18 | 5.7% |
| 8 | ESPEE BIOPHARMA FINECHEM LLC, | $933 | 2 | 2.5% |
| 9 | HOSPIRA, A PFIZER COMPANY. | $809 | 1 | 2.2% |
| 10 | HOSPIRA A PFIZER COMPANY | $799 | 1 | 2.2% |
| 11 | BAXTERNHEALTHCARE CORPORATION | $764 | 1 | 2.1% |
| 12 | FRESENIUS KABI USA LLC. | $472 | 4 | 1.3% |
| 13 | VIATRIS PHARMACEUTICALS LLC | $311 | 1 | 0.8% |
| 14 | AMGEN INC | $98 | 1 | 0.3% |
| 15 | ESPEE BIOPHARMA & FINECHEM LLC | $61 | 1 | 0.2% |
Ranked by import value (USD)
| # | Buyer | Value (USD) | Shipments | Share |
|---|---|---|---|---|
| 1 | AUROBINDO PHARMA LTD | $10.9K | 1 | 29.6% |
| 2 | ZYDUS LIFESCIENCES LIMITED | $5.9K | 18 | 15.9% |
| 3 | INDOCO REMEDIES LIMITED | $5.3K | 1 | 14.2% |
| 4 | ORBION PHARMACEUTICALS PRIVATE LIMITED | $4.8K | 2 | 12.9% |
| 5 | ALEMBIC PHARMACEUTICALS LIMITED | $3.3K | 7 | 8.9% |
| 6 | AJANTA PHARMA LIMITED | $2.4K | 1 | 6.4% |
| 7 | PFIZER HEALTHCARE INDIA PRIVATE LIMITED | $1.9K | 3 | 5.2% |
| 8 | MACLEODS PHARMACEUTICALS LTD | $933 | 2 | 2.5% |
| 9 | Syngene International Limited Unit IV BLOCK S 12 | $862 | 2 | 2.3% |
| 10 | FRESENIUS KABI ONCOLOGY LIMITED | $533 | 5 | 1.4% |
| 11 | CADILA HEALTHCARE LIMITED | $155 | 1 | 0.4% |
| 12 | CADILA HEALTHCARE LTD | $33 | 1 | 0.1% |
Answers based on Indian Customs (DGFT) import records compiled by TransData Nexus
The top Azithromycin suppliers from UNITED STATES to India include AMSTERDAM PHARMA(APTEKA RX INC.), ADIRA MEDICA LLC., BIONPHARMA INC.,. The leading supplier is AMSTERDAM PHARMA(APTEKA RX INC.) with import value of $10.9K USD across 1 shipments. India imported Azithromycin worth $36.9K USD from UNITED STATES in total across 44 shipments.
India imported Azithromycin worth $36.9K USD from UNITED STATES across 44 shipments. Data is from Indian Customs (DGFT) records. Values are in USD.
The main Indian buyers of Azithromycin sourced from UNITED STATES include AUROBINDO PHARMA LTD, ZYDUS LIFESCIENCES LIMITED, INDOCO REMEDIES LIMITED. The largest buyer is AUROBINDO PHARMA LTD with $10.9K in imports across 1 shipments.
The total value of Azithromycin imports from UNITED STATES to India is $36.9K USD, across 44 shipments and 15 foreign suppliers. Data source: Indian Customs (DGFT).
Data sourced from Indian Customs (DGFT) records. Verify regulatory and trade status with the agencies above.
Pharmaceutical Export-Import Analyst & Trade Intelligence Expert
Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.
linkedin.com/in/sureshsormareAll trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.
Government-Sourced Data
Official DGFT customs records
Transparent Methodology
Calculations fully disclosed above
44 Verified Shipments
15 suppliers, 12 buyers tracked
Expert-Reviewed
By pharmaceutical trade specialists